Viewing Study NCT02318095


Ignite Creation Date: 2025-12-24 @ 2:05 PM
Ignite Modification Date: 2026-02-20 @ 4:44 PM
Study NCT ID: NCT02318095
Status: COMPLETED
Last Update Posted: 2023-10-26
First Post: 2014-12-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer
Sponsor: Duke University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Resectable Pancreatic Cancers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer of the pancreas View